台股 » 個股 » 佳醫 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

佳醫

(4104)
可現股當沖
  • 股價
    87.3
  • 漲跌
    ▲0.1
  • 漲幅
    +0.11%
  • 成交量
    298
  • 產業
    上市 生技醫療類股
  • 331人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
佳醫 (4104)籌碼相關-元富-烏日 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1202/2403/1803/2804/1003/0677.58082.58587.59092.5May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

元富-烏日 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/08180.6100.0084.9011340.76%
2025/04/07179.5200.0079.9011220.82%
2025/04/02188.3000.0088.3011040.95%
2025/04/01388.1300.0088.1031042.87%
2025/03/31387.7000.0087.7031022.94%
2025/03/28388.9300.0088.803983.04%
2025/03/19090.0000.0089.800960.00%
2025/03/17088.8000.0088.500910.02%
2025/03/10089.3000.0089.500860.03%
2025/02/1900.000.186.5086.20-0.172-0.15%
2025/02/17086.5000.0086.400750.03%
2025/02/10086.6000.0086.400760.03%
2025/01/15085.2000.0084.900760.03%
2025/01/08085.2000.0085.000760.03%
2024/11/15086.4000.0086.100850.03%
2024/11/08087.5000.0087.300910.02%
2024/10/14087.5000.0087.2001150.01%
2024/10/08087.8000.0087.2001170.02%
2024/09/16087.7000.0087.3001270.02%
2024/09/09087.7000.0087.5001320.02%
2024/08/20091.2000.0091.8001390.00%
2024/08/15092.0000.0092.3001400.01%
2024/08/14090.3000.0090.6001350.01%
2024/08/08087.3000.0087.4001370.02%
2024/07/15089.6000.0089.3001570.01%
2024/07/0800.00090.2090.000186-0.01%
2024/07/03090.5000.0090.1002000.01%
2024/07/01189.9000.0090.0012020.49%
2024/06/24090.6000.0090.2002170.00%
2024/06/17090.5000.0090.4002280.01%
2024/06/1400.00390.0090.20-3230-1.30%
2024/06/12090.3000.0090.0002380.00%
2024/06/110.290.400.390.4090.00-0.1241-0.05%
2024/05/300.189.7000.0089.100.12810.04%
2024/05/20091.5000.0091.3002970.00%
2024/05/1400.000.390.8090.50-0.3300-0.09%
2024/05/090.192.2000.0091.900.12940.03%
2024/05/08092.3000.0091.8002940.01%
2024/04/29091.6000.0091.4002850.00%
2024/04/18494.5000.0094.6042661.50%
2024/04/17094.7000.0094.6002590.00%
2024/04/150.196.5000.0096.200.12450.04%
2024/04/1200.001.196.1196.30-1.1239-0.47%
佳醫整併血液透析通路效益顯 下半年營運拚成長Anue鉅亨-2022/09/28
〈佳醫法說〉東南亞市場將調整產品結構 2-3年後可望發酵Anue鉅亨-2020/09/24
佳醫 相關文章
佳醫 相關影音